T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.
about
Use of licensed vaccines for active immunization of the immunocompromised hostPaucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromeCD8(+) T cells implicated in the pathogenesis of allergic fungal rhinosinusitisCryptococcal interactions with the host immune system.Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells.Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptorsA mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survivalCharacterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans.Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in miceAntibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cellsAggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivoDifferential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolatesThe capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibodyRequirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice.Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans.Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected UgandansDifferences in components at delayed-type hypersensitivity reaction sites in mice immunized with either a protective or a nonprotective immunogen of Cryptococcus neoformansImmunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.Immunoregulation by capsular components of Cryptococcus neoformans.Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune responseDectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.Cryptococcal infection and Th1-Th2 cytokine balance.Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.Host defence to pulmonary mycosisTreatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice.Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.Antibody therapy for histoplasmosis.Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.New concepts in antibody-mediated immunity.IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigensVaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclassesA novel glyco-conjugate vaccine against fungal pathogens.Protective and destructive immunity in the periodontium: Part 1--innate and humoral immunity and the periodontium.
P2860
Q24533456-7A08FD8D-F6B6-441A-8A79-04A6BC2B526EQ24630287-BCC2BD8B-FF01-42E0-B135-F96D943EF85EQ28384864-3B86A494-3D18-4F85-AAF5-1D0BBCC80DF5Q30387948-559D4E16-E0B3-4838-9FA0-E6C623C7621DQ31098317-475BCF80-AF38-4480-9B94-FCBF39B7DB7AQ33556794-7AF688F0-5286-43F6-9751-ABB3C0A832CAQ33562297-BFD998B6-4C81-4609-A92E-4BE8E507A4FBQ33606785-E40D985A-3D14-4C39-A934-5CB202797A03Q33693515-769B886A-BB2F-449C-877A-36B5A9A32086Q33716138-DE0AB80B-3DE3-48BC-B972-7B1E4C3C766CQ33751509-3E99675B-5596-4EC8-A49A-5F7A4FAF84E3Q33793546-975FF7E0-DB11-4128-ACC3-F8091F4662DCQ33825652-37CB84D1-B8B3-49A3-A755-8EC3AFA2594AQ33877219-13F8FF40-134B-4CA0-8435-339B04FCB82BQ34001769-DA3BB49C-CF97-4D7B-8647-98649DED6D57Q34003156-803E0C21-CB5E-4BB0-A9FB-CBD81EFFC8DCQ34003768-B8BC81BD-081C-44AA-B1AB-241E54751236Q34009446-87A53056-0F9F-4D09-9B37-AAA2AE352637Q34072411-3BB692E0-A8CE-429F-97AB-745D5763D9CBQ34118259-F0BBBB10-B842-45DF-BCA3-D5220FECD3DCQ34121516-14FC67D6-1090-4C0B-A2D7-65C55C802CFAQ34122405-7834E506-52A2-4A3E-B453-85A8085A834EQ34131697-94870361-B0BA-4B60-BC2F-206E5AB6E7F8Q34155052-47308CBD-001B-4472-9210-9408A0049C70Q34530189-9D8BEAD4-F41A-44D4-A760-335C457468AEQ34955594-BA249757-C95A-4EDE-B8D9-36AD940CF0C2Q35027538-60C6ABD8-3270-4173-87E6-DEDDF2C4CE16Q35182322-87963F3B-0380-408C-8734-9B2219678B2DQ35649657-7E7424B8-4214-461E-A386-616CD6AB5586Q35666553-82C2CCA2-1730-4BB0-A1D5-390D5F52282BQ35689463-47A9AF96-8EDF-47E3-A0E9-4DD3189F5652Q35724334-8D2A0415-AD46-41EF-A6DB-E79857C6C6D9Q35783722-6CF712D0-96A4-44B9-BA96-36C03216BAB6Q35926507-CCB11F5C-4DEB-4719-B50B-BBCB640690D5Q35952109-775CFD10-B63B-4081-8311-D8999C005501Q36017488-C1905101-CF7C-4EE9-AA70-61ED9B279865Q36192774-F939076C-09A0-4198-910C-354D9DEF7147Q36400281-2B6BF60C-0C0B-4DD5-AFA1-257428BE4009Q36402820-189FF8A2-1A8F-47FF-86D7-61863E25A4EEQ36404749-178F411E-D803-4D06-B7EB-903681A119E4
P2860
T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
T cells cooperate with passive ...... neoformans infection in mice.
@ast
T cells cooperate with passive ...... neoformans infection in mice.
@en
type
label
T cells cooperate with passive ...... neoformans infection in mice.
@ast
T cells cooperate with passive ...... neoformans infection in mice.
@en
prefLabel
T cells cooperate with passive ...... neoformans infection in mice.
@ast
T cells cooperate with passive ...... neoformans infection in mice.
@en
P2093
P2860
P356
P1476
T cells cooperate with passive ...... neoformans infection in mice.
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.6.2483
P407
P577
1997-03-01T00:00:00Z